Alessandro R.
- Country
- Italy
- Department
- 3906: Ematologia
Research Overview
- Safety Evaluation of CC-93269 in Patients with Relapsed and Refractory Multiple Myeloma
- Phase I/II Evaluation of NMS-03592088, a FLT3, KIT, and CSF1R Inhibitor, in Relapsed/Refractory Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
- Phase I/II Evaluation of PTG-CARCIK-CD19 in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Data & Insights
Has run more than one trial at 142 of 240 partner sites.
Specializations
Multiple Myeloma Research
Specializes in treating multiple myeloma with particular focus on relapsed and refractory cases. Investigates novel therapeutic approaches including combination treatments with agents like cevostamab, teclistamab, and innovative drug combinations.
- Pre-transplant induction therapy
- Post-transplant consolidation treatments
- High-risk smoldering multiple myeloma
Leukemia Studies
Conducts extensive research in various forms of leukemia, with specialized focus on both acute myeloid leukemia and chronic lymphocytic leukemia. Explores innovative treatment combinations and targeted therapies.
- Novel therapeutic combinations
- Treatment-resistant cases
- Targeted molecular therapies
Lymphoma and Blood Disorders
Focuses on treating various types of lymphomas and related blood disorders, including diffuse large B-cell lymphoma and myeloproliferative neoplasms. Explores innovative treatment approaches using targeted therapies.
- B-cell lymphoma treatments
- Myeloproliferative disorders
- Graft versus host disease
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.